Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
PaperCitations, authors & open-access status
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 44 citations, 2023 year and gold oa status.
44
Citations
2023
Year
gold
OA Status